Literature DB >> 11460028

Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in Canadian women: HSV-2 prevalence increases throughout the reproductive years.

D M Patrick1, M Dawar, D A Cook, M Krajden, H C Ng, M L Rekart.   

Abstract

BACKGROUND: This study sought to provide the first population estimates of herpes simplex type 2 (HSV-2) seroprevalence in Canada. GOAL: To measure the antenatal seroprevalence of HSV-2 antibodies in reproductive age women. STUDY
DESIGN: An anonymous unlinked seroprevalence study used stored sera collected from pregnant women in British Columbia during 1999. Randomized sampling within age strata selected a total of 1215 subjects, ages 15 to 44 years. Serologic testing used the Gull Meridian Test. Overall prevalence was directly standardized to the 1999 Canadian female population.
RESULTS: The age-adjusted prevalence for HSV-2 was 17.3% (95% CI, 15.2-19.4). Prevalence ranged from 7.1% (ages, 15-19 years) to 28.1% (ages, 40-44 years), with the largest increases after the age of 24 years.
CONCLUSIONS: The HSV-2 seroprevalence among pregnant women in British Columbia is similar to that in the United States and other countries. Seroprevalence continues to rise through the later reproductive years. This observation may relate to continued transmission, an age cohort effect, or both.

Entities:  

Mesh:

Year:  2001        PMID: 11460028     DOI: 10.1097/00007435-200107000-00011

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  10 in total

Review 1.  Genital herpes simplex virus infection in the adolescent: special considerations for management.

Authors:  Lawrence R Stanberry; Susan L Rosenthal
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

2.  Safety of antiviral medication for the treatment of herpes during pregnancy.

Authors:  So-Hee Kang; Angela Chua-Gocheco; Pina Bozzo; Adrienne Einarson
Journal:  Can Fam Physician       Date:  2011-04       Impact factor: 3.275

3.  Prevention and management of neonatal herpes simplex virus infections.

Authors:  Upton D Allen; Joan L Robinson
Journal:  Paediatr Child Health       Date:  2014-04       Impact factor: 2.253

4.  Using centralized laboratory data to monitor trends in herpes simplex virus type 1 and 2 infection in British Columbia and the changing etiology of genital herpes.

Authors:  Mark Gilbert; Xuan Li; Martin Petric; Mel Krajden; Judith L Isaac-Renton; Gina Ogilvie; Michael L Rekart
Journal:  Can J Public Health       Date:  2011 May-Jun

5.  The diagnosis of genital herpes - beyond culture: An evidence-based guide for the utilization of polymerase chain reaction and herpes simplex virus type-specific serology.

Authors:  S Ratnam; A Severini; G Zahariadis; M Petric; B Romanowski
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-07       Impact factor: 2.471

6.  Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, Canada.

Authors:  Michelle Howard; John W Sellors; Dan Jang; Noah J Robinson; Margaret Fearon; Janusz Kaczorowski; Max Chernesky
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

7.  The Epidemiology of Herpes Simplex Virus Type-2 Infection among Pregnant Women in Rural Mysore Taluk, India.

Authors:  Aaron F Bochner; Purnima Madhivanan; Bhavana Niranjankumar; Kavitha Ravi; Anjali Arun; Karl Krupp; Jeffrey D Klausner
Journal:  J Sex Transm Dis       Date:  2013-11-14

8.  Seroprevalence of Herpes Simplex Virus type-2 (HSV-2) among pregnant women who participated in a national HIV surveillance activity in Haiti.

Authors:  Jean Wysler Domercant; Frantz Jean Louis; Erin Hulland; Mark Griswold; Jocelyne Andre-Alboth; Tun Ye; Barbara J Marston
Journal:  BMC Infect Dis       Date:  2017-08-18       Impact factor: 3.090

9.  Epidemiological impact of a genital herpes type 2 vaccine for young females.

Authors:  Yijun Lou; Redouane Qesmi; Qian Wang; Marc Steben; Jianhong Wu; Jane M Heffernan
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

10.  What is new from the Canadian Paediatric Society Committee on Infectious Diseases and Immunization?

Authors:  Joan Robinson
Journal:  Can J Infect Dis Med Microbiol       Date:  2014-05       Impact factor: 2.471

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.